Skip to main content
Article
Effects of chronic clomipramine on central DADLE antinociception
Pain
  • Frederick J. Goldstein, Philadelphia College of Osteopathic Medicine
  • R. T. Malseed
  • J. F. Nutz
Document Type
Article
Publication Date
1-1-1990
Abstract

Equipotent antinociceptive doses, as determined by a tail-flick response, for centrally administered (periaqueductal gray) morphine (M) and d-Ala2, d-Leu5 enkephalin (DADLE) were established as 5 μg and 19 μg, respectively. Chronic (28 day) subcutaneous infusion of clomipramine (CMI) via an Alzet minipump attenuated both central M-and DADLE-induced analgesia by day 15; attenuation persisted for the duration of the infusion (day 29). Within 7 days following removal of the pump, antinociceptive responses to M and DADLE returned to near pre-CMI Ievels. Our results indicate a similarity between M and DADLE with regard to attenuation of their antinociceptive action by chronic CMI. This attenuation may be due to decreased mu opioid receptor sensitivity or density resulting from chronic tricyclic antidepressant administration. © 1990.

Comments

This article was published in Pain, Volume 42, Issue 3, Pages 331-336.

The published version is available at http://dx.doi.org/10.1016/0304-3959(90)91146-A.

Copyright © 1990.

Citation Information
Frederick J. Goldstein, R. T. Malseed and J. F. Nutz. "Effects of chronic clomipramine on central DADLE antinociception" Pain Vol. 42 Iss. 3 (1990) p. 331 - 336
Available at: http://works.bepress.com/frederick_goldstein/14/